• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚囊性纤维化成人患者的重症疾病负担:一项在线调查的结果。

Critical disease burdens of Australian adults with cystic fibrosis: Results from an online survey.

机构信息

Faculty of Health, Southern Cross University, Coolangatta, Queensland, Australia.

International Rice Research Institute, Laguna, Philippines.

出版信息

Pediatr Pulmonol. 2023 Jul;58(7):1931-1941. doi: 10.1002/ppul.26413. Epub 2023 Apr 25.

DOI:10.1002/ppul.26413
PMID:37097078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10947436/
Abstract

BACKGROUND

The objective of this study was to conduct a web-based questionnaire to investigate self-reported phenotypes and disease burdens of individuals living in Australia and diagnosed with cystic fibrosis (CF) using a case-control study design.

METHODS

An online questionnaire was distributed to individuals with CF and healthy control subjects. Overall health rating, medications, family history, education, clinical indicators of disease, and symptoms, including their severity and frequency, were evaluated.

RESULTS

There was a total of 119 respondents consisting of 59 people living with CF and 60 controls. The CF cohort had significantly lower tertiary educational levels compared to controls. The analysis specific to the CF cohort depicted a significant correlation between the frequency of hospitalizations and the level of education in the CF cohort. Of the 26 self-reported symptoms of CF that were analyzed, 14 were significantly higher in the people living with CF. The CF cohort reporting symptoms of chronic pain (25%) described an increase in the burden of disease, depicting a 30% longer mean hospitalization, increased consumption of medications and significant relationships with four other symptoms, including muscle aches, digestive issues, pancreatic insufficiency, and abdominal swelling.

CONCLUSIONS

The nationwide survey identified a diverse range of clinical manifestations experienced by the Australian CF population. Chronic pain, linked to aging and the changing landscape of disease, was a significant indicator of the burden of disease. A comprehensive understanding of the phenotypic profiles and symptom variability will contribute to future research and provide insights into the impacts of disease and the burden of therapy, particularly in children, at the start of their health journey.

摘要

背景

本研究旨在采用病例对照研究设计,通过网络问卷调查,调查居住在澳大利亚并被诊断为囊性纤维化 (CF) 的个体的自我报告表型和疾病负担。

方法

向 CF 患者和健康对照者分发在线问卷。评估总体健康状况评分、药物使用情况、家族史、教育程度、疾病临床指标以及症状,包括其严重程度和频率。

结果

共有 119 名受访者,包括 59 名 CF 患者和 60 名对照者。CF 队列的高等教育程度明显低于对照组。针对 CF 队列的分析表明,住院频率与 CF 队列的教育程度之间存在显著相关性。在分析的 26 项 CF 自我报告症状中,有 14 项在 CF 患者中明显更高。报告慢性疼痛症状(25%)的 CF 患者描述了疾病负担的增加,表明平均住院时间延长了 30%,药物消耗增加,并与包括肌肉疼痛、消化问题、胰腺功能不全和腹部肿胀在内的其他 4 种症状存在显著关系。

结论

全国性调查确定了澳大利亚 CF 人群所经历的各种临床表现。慢性疼痛与年龄增长和疾病变化的环境有关,是疾病负担的一个重要指标。对表型特征和症状变异性的全面了解将有助于未来的研究,并深入了解疾病的影响和治疗负担,特别是在儿童开始其健康之旅时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a139/10947436/16a255b0dc87/PPUL-58-1931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a139/10947436/a5954b0f710c/PPUL-58-1931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a139/10947436/b4d86418ecbd/PPUL-58-1931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a139/10947436/16a255b0dc87/PPUL-58-1931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a139/10947436/a5954b0f710c/PPUL-58-1931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a139/10947436/b4d86418ecbd/PPUL-58-1931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a139/10947436/16a255b0dc87/PPUL-58-1931-g001.jpg

相似文献

1
Critical disease burdens of Australian adults with cystic fibrosis: Results from an online survey.澳大利亚囊性纤维化成人患者的重症疾病负担:一项在线调查的结果。
Pediatr Pulmonol. 2023 Jul;58(7):1931-1941. doi: 10.1002/ppul.26413. Epub 2023 Apr 25.
2
Topical fluoride as a cause of dental fluorosis in children.局部用氟化物是导致儿童氟斑牙的原因。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD007693. doi: 10.1002/14651858.CD007693.pub3.
3
Risk of Pancreatic Cancer in Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Germline Variants: A Retrospective Cohort Study.囊性纤维化及囊性纤维化跨膜传导调节因子种系变异与胰腺癌风险:一项回顾性队列研究
Clin Transl Gastroenterol. 2025 May 27. doi: 10.14309/ctg.0000000000000857.
4
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
5
Multifaceted behavioral interventions to improve topical glaucoma therapy adherence in adults.多方面行为干预以提高成人局部青光眼治疗的依从性。
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD015788. doi: 10.1002/14651858.CD015788.pub2.
6
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.
7
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy.囊性纤维化跨膜传导调节因子调节剂对孕期及产后母体结局的影响。
Chest. 2025 Feb;167(2):348-361. doi: 10.1016/j.chest.2024.09.019. Epub 2024 Sep 27.
8
Mucolytics for children with chronic suppurative lung disease.用于患有慢性化脓性肺病儿童的黏液溶解剂。
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD015313. doi: 10.1002/14651858.CD015313.pub2.
9
Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis.迈向以患者为中心的特应性皮炎发作定义:一项特应性皮炎成人患者的定性研究。
Br J Dermatol. 2024 Jun 20;191(1):82-91. doi: 10.1093/bjd/ljae037.
10
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.

引用本文的文献

1
Impact of Gene Modifiers on Cystic Fibrosis Phenotypic Profiles: A Systematic Review.基因修饰因子对囊性纤维化表型谱的影响:一项系统综述。
Hum Mutat. 2024 Oct 16;2024:6165547. doi: 10.1155/2024/6165547. eCollection 2024.
2
The Anion Channel TMEM16a/Ano1 Modulates CFTR Activity, but Does Not Function as an Apical Anion Channel in Colonic Epithelium from Cystic Fibrosis Patients and Healthy Individuals.阴离子通道 TMEM16a/Ano1 调节 CFTR 活性,但在囊性纤维化患者和健康个体的结肠上皮中不作为顶端阴离子通道发挥作用。
Int J Mol Sci. 2023 Sep 18;24(18):14214. doi: 10.3390/ijms241814214.

本文引用的文献

1
Survival of people with cystic fibrosis in Australia.澳大利亚囊性纤维化患者的生存状况。
Sci Rep. 2022 Nov 17;12(1):19748. doi: 10.1038/s41598-022-24374-4.
2
Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies.谁是那 10%?——囊性纤维化 (CF) 患者不符合高效调节剂治疗的条件。
Respir Med. 2022 Aug;199:106878. doi: 10.1016/j.rmed.2022.106878. Epub 2022 May 16.
3
Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry.囊性纤维化数据注册研究中患者报告结局测量(PROMs)的可接受性。
BMJ Open Respir Res. 2021 Jul;8(1). doi: 10.1136/bmjresp-2021-000927.
4
CFTR gene variants, epidemiology and molecular pathology.囊性纤维化跨膜传导调节因子基因变异、流行病学与分子病理学
Arch Pediatr. 2020 Feb;27 Suppl 1:eS8-eS12. doi: 10.1016/S0929-693X(20)30044-0.
5
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.CFTR调节剂:精准医学时代囊性纤维化的新面貌
Front Pharmacol. 2020 Feb 21;10:1662. doi: 10.3389/fphar.2019.01662. eCollection 2019.
6
Cystic fibrosis in the year 2020: A disease with a new face.2020年的囊性纤维化:面貌一新的疾病。
Acta Paediatr. 2020 May;109(5):893-899. doi: 10.1111/apa.15155. Epub 2020 Jan 22.
7
The future of cystic fibrosis care: a global perspective.囊性纤维化护理的未来:全球视角。
Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27.
8
Results from an online survey of adults with cystic fibrosis: Accessing and using life expectancy information.一项针对成年囊性纤维化患者的在线调查结果:获取和使用预期寿命信息。
PLoS One. 2019 Apr 12;14(4):e0213639. doi: 10.1371/journal.pone.0213639. eCollection 2019.
9
Health-Related Quality of Life in Adolescents and Adults With Cystic Fibrosis: Physical and Mental Health Predictors.囊性纤维化青少年和成人的健康相关生活质量:身体和心理健康的预测因素。
Respir Care. 2019 Apr;64(4):406-415. doi: 10.4187/respcare.06356. Epub 2018 Sep 25.
10
Predicting disease progression in cystic fibrosis.预测囊性纤维化的疾病进展。
Expert Rev Respir Med. 2018 Nov;12(11):905-917. doi: 10.1080/17476348.2018.1519400. Epub 2018 Sep 13.